Skip to main content
Fig. 7 | Cancer Cell International

Fig. 7

From: Comprehensive bioinformatics analysis of the solute carrier family and preliminary exploration of SLC25A29 in lung adenocarcinoma

Fig. 7

The down-regulation of SLC25A29 expression was related to lactylation modification in HUVEC. (A) Lactate content in HUVEC. (B) Western blot was performed to test the relationship between SLC25A29 expression levels and lactate. (C) Distribution of six primers on the SLC25A29 genomic sequence. (D) ChIP-qPCR assay of H3K18la status in the SLC25A29 genomic region in HUVEC. (E) ChIP-qPCR assay of H3K14la status in the SLC25A29 genomic region in HUVEC. (F) ChIP-qPCR assay of H3K9la status in the SLC25A29 genomic region in HUVEC. (G)Relative lactate content within the culture medium. (H) and (I) ECAR of HUVEC under different cultivation conditions

Back to article page